Artificial intelligence could change the pharmaceutical industry by making drug discovery and development faster and more efficient. There are several main ways that AI is used in the pharmaceutical industry. These include computer-aided drug design, the analysis of large amounts of data, and optimizing drug sales across stores.
Computer-aided drug design is the use of machine learning algorithms to predict the potential efficiency and toxicity of new drug compounds. This can greatly reduce the time and cost of drug discovery by allowing researchers to quickly identify promising compounds and eliminate those that are unlikely to be effective. For example, researchers can use AI to predict the binding affinity of a drug compound to a specific protein target, which is an important factor in determining its potential efficiency. Additionally, AI can be used to predict potential toxicity by identifying potential unintended effects of a drug , which can help to reduce the risk of side effects in patients.
Another application of AI in the pharmaceutical industry is in the analysis of large amounts of data, such as electronic health records and clinical trial data. This can help to identify new drug targets, predict patient response to treatment, and improve clinical trial design. For example, AI can be used to analyze electronic health records to identify patient subgroups that are more likely to respond to a particular treatment, which can help to optimize clinical trial design and increase the chances of success. Additionally, AI can be used to identify new drug targets by analyzing large amounts of demographic data, which can help to accelerate the drug discovery process.
Another use of big data science in pharmaceutical industry focuses not directly on drug development, but rather on increasing sales of medicines. For instance with the use of electronic prescriptions specific programs can predict which other medications patients will be willing to purchase during treatment, by analyzing pre scripted meds. This can not only increase the sales of a pharmacy, but also speed up the convalescence process.
To summarize I believe that AI has already tremendously changed the pharmaceutical industry, and will be used even more widely in the future. However there is a possibility that drug concerns will use AI only for own purposes, rather than providing better medicines, but since drug sector is heavily regulated in every country I don’t see that coming.
Sources:
https://www.ft.com/content/e450a688-ddfb-11e8-b173-ebef6ab1374a
https://www.ft.com/content/3e57ad6c-493d-4874-a663-0cb200d3cdb5
https://www.pharmaceuticaltechnology.com/sector/theme/technology/artificial-intelligence/
The fact that artificial intelligence helps people is amazing. Especially in such a necessary and important area for people as health, pharmaceuticals and medicines. I am not a scientist or a doctor, but I would not rely 100 percent on artificial intelligence in the field of health, as the slightest mistake can do terrible things. But if everything has been checked more than once and really helps doctors, then this is great, because in many areas artificial intelligence and technology make life easier for people. And I am sure that in the future there will be even more discoveries with the help of humans and artificial intelligence in the field of health.
The use of computer-aided drug design is an exciting development that can greatly reduce the time and cost of drug discovery by allowing researchers to quickly identify promising compounds and eliminate those that are unlikely to be effective. This can be done by using machine learning algorithms to predict the potential efficiency and toxicity of new drug compounds. Additionally, AI can be used to predict potential toxicity by identifying potential unintended effects of a drug, which can help to reduce the risk of side effects in patients. Another application of AI in the pharmaceutical industry is in the analysis of large amounts of data, such as electronic health records and clinical trial data. This can help to identify new drug targets, predict patient response to treatment, and improve clinical trial design. By analyzing electronic health records, AI can help to identify patient subgroups that are more likely to respond to a particular treatment, which can help to optimize clinical trial design and increase the chances of success.
in my opinion, drug companies may use AI only for their own purposes, rather than using it to provide better medicines. The author suggests that there is a potential for drug companies to prioritize their own financial gain over the well-being of patients, by using AI for cost-cutting and sales optimization rather than for improving the quality of drugs and patient outcomes.